Please Wait
Applying Filters...
menu
    • menu
    Evonik

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

    Virtual Booth

    Contact Supplier

    Temad- We think of world-class quality.

    Virtual Booth

    Contact Supplier

    Menu

    Brodalumab

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 8Lumicef

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Lumicef

    Brodalumab

    arrow
    The Battery Show
    Not Confirmed

    Brand Name : Lumicef

    Japan
    arrow
    The Battery Show
    Not Confirmed

    Kyowa Kirin

    Brodalumab

    Main Therapeutic Indication : Dermatology

    Currency : USD

    2020 Revenue in Millions : 27

    2019 Revenue in Millions : 24

    Growth (%) : 12

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Lumicef

    Brodalumab

    arrow
    The Battery Show
    Not Confirmed

    Brand Name : Lumicef

    Japan
    arrow
    The Battery Show
    Not Confirmed

    Kyowa Kirin

    Brodalumab

    Main Therapeutic Indication : Dermatology

    Currency : USD

    2021 Revenue in Millions : 24

    2020 Revenue in Millions : 27

    Growth (%) : 4

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Lumicef

    Brodalumab

    arrow
    The Battery Show
    Not Confirmed

    Brand Name : Lumicef

    Japan
    arrow
    The Battery Show
    Not Confirmed

    Kyowa Kirin

    Brodalumab

    Main Therapeutic Indication : Dermatology

    Currency : USD

    2022 Revenue in Millions : 23

    2021 Revenue in Millions : 24

    Growth (%) : -7

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Lumicef

    Brodalumab

    arrow
    The Battery Show
    Not Confirmed

    Brand Name : Lumicef

    Japan
    arrow
    The Battery Show
    Not Confirmed

    Kyowa Kirin

    Brodalumab

    Main Therapeutic Indication : Dermatology

    Currency : USD

    2023 Revenue in Millions : 19

    2022 Revenue in Millions : 23

    Growth (%) : -7

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Lumicef

    Brodalumab

    arrow
    The Battery Show
    Not Confirmed

    Brand Name : Lumicef

    Japan
    arrow
    The Battery Show
    Not Confirmed

    Kyowa Kirin

    Brodalumab

    Main Therapeutic Indication : Dermatology

    Currency : USD

    2024 Revenue in Millions : 18

    2023 Revenue in Millions : 19

    Growth (%) : -6

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Lumicef

    Brodalumab

    arrow
    The Battery Show
    Not Confirmed

    Brand Name : Lumicef

    Japan
    arrow
    The Battery Show
    Not Confirmed

    Kyowa Kirin

    Brodalumab

    Main Therapeutic Indication : Dermatology

    Currency : USD

    2017 Revenue in Millions : 10

    2016 Revenue in Millions : 1

    Growth (%) : 900

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Lumicef

    Brodalumab

    arrow
    The Battery Show
    Not Confirmed

    Brand Name : Lumicef

    Japan
    arrow
    The Battery Show
    Not Confirmed

    Kyowa Kirin

    Brodalumab

    Main Therapeutic Indication : Dermatology

    Currency : USD

    2018 Revenue in Millions : 13

    2017 Revenue in Millions : 9

    Growth (%) : 40%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Lumicef

    Brodalumab

    arrow
    The Battery Show
    Not Confirmed

    Brand Name : Lumicef

    Japan
    arrow
    The Battery Show
    Not Confirmed

    Kyowa Kirin

    Brodalumab

    Main Therapeutic Indication : Dermatology

    Currency : USD

    2019 Revenue in Millions : 23

    2018 Revenue in Millions : 19

    Growth (%) : 25

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF